Flagship Ventures Management
Latest statistics and disclosures from Flagship Pioneering's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by Flagship Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Moderna (MRNA) | 52.3 | $310M | 4.6M | 66.83 |
|
|
| Foghorn Therapeutics (FHTX) | 19.9 | $118M | 13M | 9.31 |
|
|
| Sana Biotechnology (SANA) | 17.6 | $104M | 25M | 4.16 |
|
|
| Omega Therapeutics (OMGA) | 6.0 | $36M | 29M | 1.22 |
|
|
| Seres Therapeutics (MCRB) | 3.7 | $22M | 23M | 0.95 |
|
|
| Syros Pharmaceuticals (SYRS) | 0.5 | $2.8M | 1.3M | 2.15 |
|
Past Filings by Flagship Pioneering
SEC 13F filings are viewable for Flagship Pioneering going back to 2016
- Flagship Pioneering 2024 Q3 filed Nov. 14, 2024
- Flagship Pioneering 2024 Q2 filed Aug. 14, 2024
- Flagship Pioneering 2024 Q1 filed May 15, 2024
- Flagship Pioneering 2023 Q4 filed Feb. 14, 2024
- Flagship Pioneering 2023 Q3 filed Nov. 14, 2023
- Flagship Pioneering 2023 Q2 filed Aug. 14, 2023
- Flagship Pioneering 2023 Q1 filed May 15, 2023
- Flagship Pioneering 2022 Q4 filed Feb. 14, 2023
- Flagship Pioneering 2022 Q3 filed Nov. 14, 2022
- Flagship Pioneering 2022 Q2 filed Aug. 15, 2022
- Flagship Pioneering 2022 Q1 filed May 16, 2022
- Flagship Pioneering 2021 Q4 filed Feb. 14, 2022
- Flagship Pioneering 2021 Q3 filed Nov. 15, 2021
- Flagship Pioneering 2021 Q2 filed Aug. 16, 2021
- Flagship Pioneering 2021 Q1 filed May 17, 2021
- Flagship Pioneering 2020 Q4 filed Feb. 16, 2021